BSN Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-200,000
Closed -$70.2M 10
2023
Q4
$70.2M Buy
+200,000
New +$70.2M 3.8% 8